



Objetivo: Comparar os parâmetros metabólicos, antropométricos, 
pressão arterial e força muscular de mulheres idosas com síndrome 
metabólica e sem síndrome metabólica. Métodos: Estudo caso-
controle com 27 (67,3±4,8 anos 31,0±5,0kg/m2) idosas com 
síndrome metabólica e 33 (68,8±5,6 anos 27,2±5,3kg/m2) idosas 
controle sedentárias. As idosas foram submetidas à avaliação de 
composição por meio da absorciometria de raio X de dupla energia 
e teste de força muscular de 10 repetições máximas na extensão de 
joelhos. Resultados: Quando comparadas às idosas sem síndrome 
metabólica, as idosas com síndrome metabólica apresentaram 
índices maiores para: massa corporal (72,2±13,5 x 63,4±14,6kg; 
p=0,03), índice de massa corporal (31,0±5,0 x 27,2±5,3kg/m2; 
p=0,007), massa gorda (30,9±9,9 x 24,4±8, 5kg; p=0,01), 
pressão arterial sistólica (125,1±8,2 x 119,3±8,7mmHg; p=0,01), 
pressão arterial diastólica (75,5±6,9 x 71,4±6,7mmHg; p=0,03), 
pressão arterial média (92,5±6,2 x 87,1±6,7mmHg; p=0,004), 
glicemia (103,8±19,1 x 91,1±5,9mg/dL; p=0,001), triglicerídeos 
(187,1±70,2 x 116,3±36,7mg/dL; p=0,001) e creatina quinase 
(122,6±58,6 x 89,8±32,5 U/L; p=0,01); foram menores: massa livre 
de gordura (55,9±5,8 x 59,3±6,7 %; p=0,05); HDL-C (40,7±5,0 x 
50,5±10,1mg/dL p=0,001) e força muscular relativa (0,53±0,14 x 
0,62±0,12; p=0,01). Conclusão: Idosas com síndrome metabólica 
apresentam maior risco cardiovascular e menor força muscular 
relativa, quando comparadas às idosas sem síndrome metabólica. A 
força muscular relativa pode estar relacionada aos fatores de risco 
cardiovascular da síndrome metabólica.
Descritores: Síndrome X metabólica/complicações; Fatores de risco/
etiologia; Doenças cardiovasculares/prevenção & controle; Força 
muscular; Envelhecimento
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ABSTRACT
Objective: To compare the metabolic, anthropometric, arterial blood 
pressure, and muscle strength parameters of elderly women with and 
without metabolic syndrome. Methods: A case-control study with 
27 (67.3±4.8 years of age, 31.0±5.0kg/m2) elderly women with 
metabolic syndrome and 33 (68.8±5.6 years of age, 27.2±5.3kg/m2) 
sedentary control elderly women. They were submitted to an evaluation 
of body composition by means of dual-energy X-ray absorptiometry 
and muscle strength testing with 10 maximal repetitions of knee 
extension. Results: When compared to the elderly women without 
metabolic syndrome, those with the metabolic syndrome had higher 
levels for body mass (72.2±13.5 versus 63.4±14.6kg, p=0.03), body 
mass index (31.0±5.0 versus 27.2±5.3kg/m2, p=0.007), fat mass 
(30.9±9.9 versus 24.4±8.5kg, p=0.01), systolic arterial pressure 
(125.1±8.2 versus 119.3±8.7mmHg, p=0.01), diastolic arterial 
pressure (75.5±6.9 versus 71.4±6.7mmHg, p=0.03), mean arterial 
pressure (92.5±6.2 versus 87.1±6.7mmHg, p=0.004), blood 
glucose (103.8±19.1 versus 91.1±5.9mg/dL, p=0.001), triglycerides 
(187.1±70.2 versus 116.3±36.7mg/dL, p=0.001), and creatine 
kinase (122.6±58.6 versus 89.8±32.5U/L, p=0.01); lower levels 
were found for fat-free mass (55.9±5.8 versus 59.3±6.7%; p=0.05), 
HDL-C (40.7±5.0 versus 50.5±10.1mg/dL, p=0.001), and relative 
muscle strength (0.53±0.14 versus 0.62±0.12, p=0.01). Conclusion: 
Elderly women with metabolic syndrome have a higher cardiovascular 
risk and less relative muscle strength when compared to those without 
metabolic syndrome. Relative muscle strength may be related to the 
cardiovascularr risk factors of the metabolic syndrome.
Keywords: Metabolic syndrome X/complications; Risk factors/
etiology; Cardiovascular diseases/prevention & control; Muscle 
strength; Aging 
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INTRODUCTION
Metabolic syndrome (MS) is characterized by cardiovascular 
risk factors, such as alterations in lipids, arterial 
hypertension, central adiposity, and insulin resistance. 
Epidemiological studies have shown strong associations 
between MS and the risk of developing cancer of the 
digestive system, diabetes, cardiovascular diseases, 
and early death(1), besides a greater use of healthcare 
services and medical costs(2). Data from the National 
Health and Nutrition Examination Survey(3) informed 
that the rates of MS prevalence were 35.1% in men and 
32.6% in women. In the central region of Brazil, Dutra 
et al.(4) reported that the MS prevalence rates were 
32%, for both males and females. 
In this respect, changes in lifestyle and especially in 
the level of physical activity may help in the treatment 
and prevention of MS(5). Additionally, the physical 
fitness components related to health, such as muscle 
strength and mass, play a significant role in carrying out 
motor tasks, decreasing the risk of falls, in addition to 
having repercussions in health, longevity, and quality 
of life of elderly people(6,7). Consequently, some studies 
showed a possible association between muscle strength 
and decrease in cardiovascular risk factors(8), obesity(9), 
high blood pressure(10), MS(11), and early death(7). 
However, the studies that analyzed the association 
between muscle strength and MS only used young men 
and women(11-14), and elderly British men(15). It must be 
emphasized that aging is also associated with a progressive 
loss of muscle strength and mass(16). We are not aware 
of any study that compares muscle strength of elderly 
Brazilian women with and without MS. The association 
of aging, which is a chronic degenerative process(16), with 
MS may increase the risk for various comorbidities, 
which differentiates this population from young people 
with MS. Therefore, the initial hypothesis of the present 
study was that elderly women with MS would have less 
relative muscle strength and greater cardiovascular risk 
when compared to women without MS.
OBJECTIVE
To compare the muscle strength of ten maximal repetitions 
(10 MR) on knee extension in elderly Brazilian women 
with and without MS, as well as to analyze if women 
at low risk showed differences in relative muscle 
strength.
METHODS
A case-control study was performed during the period 
of August 2011 to July 2012, with volunteers recruited 
by public notice in local circulation newspapers and by 
telephone contact, based on a registry at the University, 
through the Center for Social Interaction of the 
Elderly (CCI, acronym in Portuguese). Volunteers were 
selected regardless of race or social class. The study was 
approved by the Ethics and Research Committee of the 
Universidade Católica de Brasília (UCB); the Informed 
Consent Form and questionnaire on readiness for 
physical activity (PAR-Q) were obtained from all 
volunteers before inclusion in the study. The sample was 
made up of 57 volunteers divided into two groups: 27 
(67.3±4.8 years of age, 31.0±5.0kg/m2) elderly women 
with MS and 33 (68.8±5.6 years of age, 27.2±5.3kg/m2) 
without MS who did not engage in regular guided 
physical activity. 
In order to be included in the study, the participants 
needed to have been at least 6 months with no regular 
physical exercise (PAR-Q), not be in hormone replacement 
therapy (self-reported), and be aged over 60 years. The 
exclusion criteria were (1) being incapable of walking 
without assistance; (2) having a unilateral or bilateral 
hip prosthesis; (3) being a smoker, and (4) having an 
abnormality in cardiac conduction or perfusion that 
would contraindicate the physical activity.
All the volunteers were submitted to the following 
tests before muscle strength evaluation: blood sample 
collection, dual-energy X-ray absorptiometry (DEXA), 
and blood pressure evaluation.
Anthropometry
Measurements were made to enable establishing the 
anthropometric profile defined by the body mass 
index (BMI).  For body composition assessment, the 
percentages of lean mass and fat mass were analyzed 
by means of DEXA (DEXA, General Electric-GE 
model 8548 BX1L, 2005, Lunar DPX type, Encore 2005 
software). The tests included a complete body scan of 
the volunteers, in supine position, during approximately 
17 minutes, with the apparatus always regulated and 
operated by a technically trained professional. 
Biochemical analysis
The individuals were submitted to absolute rest for 30 
minutes; next, a 20mL sample of blood was collected 
from the antecubital vein by means of venous puncture, 
using the vacutainer system with EDTA anticoagulant, 
allowing determination of triglycerides by the enzymatic-
colorimetric method (GPO/POD) on Autohumalyzer 
equipment (Human GMBH, Germany). HDL-C was 
determined by ionic exchange followed by colorimetric 
reaction with the Linco® Research Inc. kit (St Louis, 
USA), and blood glucose by hexokinase enzymatic 
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assay. C-reactive protein (CRP) and creatine kinase 
(CK) were determined by turbidimetry methodology, 
intensified with particle reaction by the Cobas Mira 
Plus spectrophotometer (Roche Diagnostic, GmBH – 
Germany), with Biosystem (Bayer®) calibrator and serum 
control. Cortisol was dosed by electrochemiluminescence 
following specifications of the kit. The technique was 
developed on the Elecsys 2010 Roche Diagnostics device.
Resting arterial pressure
Determination of systolic arterial pressure (SAP) and 
diastolic arterial pressure (DAP) was performed by the 
oscillometric system, adopting the methodology proposed 
by the 5th Brazilian Guideline for Arterial Hypertension(17) 
with an oscillometric measurer (Microlife 3AC1-1, Widnau, 
Switzerland), validated by the European Society of 
Hypertension. With the elderly woman in sitting position, 
after 10 minutes of rest, the right arm supported at heart 
level, with cuff appropriate for the arm size, the cuff of the 
device was placed about 3cm above the antecubital fossa 
centralizing the rubber pouch over the humeral artery. 
The SAP and DAP values measured were used to calculate 
the mean arterial pressure (MAP) using the equation 
MAP = DAP+ [(SAP - DAP) ÷ 3].
Determining MS
The MS was identified considering the parameters 
defined by the First Brazilian Guideline for Diagnosis 
and Treatment of Metabolic Syndrome(18), which is based 
on the criteria defined by the National Cholesterol 
Education Program’s – Adult Treatment Panel III (NCEP 
– ATP III). According to NCEP – ATP III, MS represents 
the combination of at least three of the five parameters 
used to define MS: high abdominal circumference 
(in the present study we used the criterion of BMI 
≥30kg/m2), increased triglycerides (≥150mg/dL), low 
HDL-cholesterol (<50mg/dL), high fasting blood glucose 
(≥110mg/dL) or diabetes, and increased blood pressure 
(systolic pressure ≥130mmHg and/or diastolic pressure 
≥85mmHg, or use of anti-hypertensive agents).
Muscle strength test
The elderly women went through a session to become 
familiar with knee extension, with three series of 10 
submaximal repetitions. Seventy-two hours later, the 
10 MR test was performed on the extension chair 
(Cybex International, Medway, MA) as per the following 
recommendations: (1) warm-up of 5 to 10 repetitions 
with intensities of 40 to 60% of an estimated maximal 
repetition (1  MR); (2) rest for one minute, followed by 3 
to 5 repetitions with 60% of the estimated 1  MR, and rest 
for 3 minutes; (3) weight increment trying to reach 10  MR 
in 3 to 5 attempts, using 5 minutes of interval between one 
attempt and another, and 10 minutes between exercises; 
(4) the value recorded was for 10 repetitions, with the 
maximal weight lifted on the last successful attempt. To 
determine the reliability of the 10  MR tests, two tests 
were applied, with a 48-hour interval(19). Relative muscle 
strength was calculated by means of the following formula:
relative strength = absolute strength (kg)/body mass (kg)
Statistical analysis
The significance level for all variables studied was p≤0.05. 
Initially, the descriptive analysis of the sample was made 
with measurements of central tendency and dispersion. 
Next, the Kolmogorov-Smirnov test was performed to 
evaluate normality of the data and, according to the 
results, Student’s non-paired t test was used for parametric 
data, or the Mann-Whitney test for non-parametric 
data. Additionally, one-way ANOVA was used with the 
Bonferroni correction to compare the relative muscle 
strength among the elderly women with or without a 
risk factor for MS, two risk factors for MS, and more 
than three. Also performed was the correlation between 
relative muscle strength and cardiovascular risk factors, 
anthropometric factors, and biochemical factors, using 
Pearson’s correlation. Data were analyzed using Statistical 
Package for the Social Sciences (SPSS) software, version 
17.0. Assuming an effect size of 0.97 between the groups 
(based on a pilot study), a minimal sample of 11 volunteers 
for each group was required to allow an 85% power for the 
study for relative muscle strength.
RESULTS
Anthropometric, blood pressure, biochemical, and 
inflammatory parameters of the elderly women with 
and without MS are shown on table 1. No significant 
differences were observed for age (p=0.30), height 
(p=0.96), and cortisol (p=0.57). Nevertheless, when 
compared to the women without MS, those with MS had 
higher values for body mass (p=0.03), BMI (p=0.007), 
percentage of fat mass (p=0.05), fat mass (p=0.01), fat-
free mass (p=0.01), SAP (p=0.01), DAP (p=0.03), MAP 
(p=0.004), glucose (p=0.001), triglycerides (p=0.001), 
CK (p=0.01), and CRP (p=0.01). The percentages for 
fat-free mass (p=0.05), HDL-C (p=0.001), and relative 
muscle strength (p=0.01) were lower. Additionally, the 
elderly women who did not have risk factors or had 
one risk factor for MS were significantly stronger than 
those who showed two or more risk factors for MS 
(Figure 1).
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* Significant difference among groups (p=0.05).
Figure 1. Relative muscle strength for the groups. (A) With and without metabolic 
syndrome; (B) none or one (n=18) risk factor for metabolic syndrome; two (n=18) risk 
factors for metabolic syndrome; and three (n=21) risk factors for metabolic syndrome
The correlations between relative muscle strength 
and the other variables in both groups are shown on table 
2. Inverse correlations were seen for relative muscle 
strength with fat mass and fat-free mass in the group 
without MS. On the other hand, in the group with MS, 
relative muscle strength was inversely correlated with 
body mass and BMI.
DISCUSSION
Confirming the original hypothesis, the women with MS 
showed a higher cardiovascular risk and less relative 
muscle strength when compared to those without MS. 
Additionally, the results demonstrated that women with 
two or more risk factors for MS had less relative muscle 
strength when compared to those who had no risk factor 
or had one risk factor for MS.
The Framingham Offspring study(20), which included 
2,406 men and 2,569 women aged between 19 and 
74 years, examined the grouping of metabolic and 
cardiovascular factors relative to the risk of coronary 
artery diseases (CAD). The risk factors considered were 
HDL-C, BMI, SAP, triglycerides, glucose, and total 
cholesterol. The authors showed that the participants 
with three or more risk factors increased their risk of 
Table 1. Anthropometric, blood pressure and biochemical parameters of wo-





Age (years) 67.3±4.8 68.8±5.6 0.30
Height (m) 1.52±0.06 1.53±0.06 0.96
Body mass (kg) 72.2±13.5 63.4±14.6* 0.03
BMI (kg/m2) 31.0±5.0  27.2±5.3* 0.007
Fat mass (%) 44.1±5.8 40.7±6.7* 0.05
Fat mass (kg) 30.9±9.9 24.4±8.5* 0.01
Fat-free mass (%) 55.9±5.8 59.3±6.7* 0.05
Fat-free mass (kg) 38.0±4.2 35.1±4.1* 0.01
SBP (mmHg) 125.1±8.2* 119.3±8.7* 0.01
DBP (mmHg) 75.5±6.9* 71.4±6.7* 0.03
MBP (mmHg) 92.5±6.2 87.1±6.7* 0.004
TGL (mg/dL) 187.1±70.2 116.3±36.7* 0.001
Glucose (mg/dL) 103.8±19.1 91.1±5.9* 0.001
HDL (mg/dL) 40.7±5.0 50.5±10.1* 0.001
CRP (pg/mL)** 0.30 0.19* 0.01
CK (U/L) 122.6±58.6 89.8±32.5* 0.01
Cortisol (µg/dL) 14.5±4.6 15.3±5.8 0.57
*Significant difference between the groups; **Data expressed as median.
BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; MBP: mean blood pressure; TGL: 
triglycerides; HDL: high-density lipoprotein; CRP: C-reactive protein; CK: creatine kinase; MS: metabolic syndrome.
Table 2. Correlation among variables and relative muscle strength in women 
with and without metabolic syndrome 
 Without MS With MS
R p value R p value
Age (years) -0.07 0.10 -0.14 0.58
Body mass (Kg) -0.33 0.11 -0.47 0.05*
Height (m) -0.27 0.19 0.08 0.71
BMI (Kg/m²) -0.30 0.15 -0.57 0.01*
Fat mass (%) -0.47 0.01* -0.46 0.06
Fat-free mass (%) 0.47 0.01* 0.46 0.06
Fat mass (kg) -0.39 0.05* -0.45 0.06
Fat-free mass (kg) -0.19 0.35 -0.28 0.26
SBP (mmHg) 0.19 0.37 0.03 0.88
DBP (mmHg) 0.15 0.45 0.27 0.29
MBP (mmHg) 0.18 0.39 0.21 0.40
TGL (mg/dL) -0.21 0.31 0.04 0.88
HDL (mg/dL) 0.15 0.46 0.00 0.98
Glucose (mg/dL) 0.11 0.60 -0.11 0.66
Cortisol (µg/dL) -0.05 0.80 -0.14 0.58
CK (U/L) -0.15 0.47 0.24 0.34
CRP (mg/dL) -0.09 0.64 0.30 0.23
* Significant correlation (p<0.05).
BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; MBP: mean blood pressure; TGL: 
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developing CAD 2.4 times for men and 5.9 times for 
women when compared to volunteers with no risk 
factor. Forti et al.(21) demonstrated that the probability 
all causes of mortality in elderly women with MS (70 
to 79 years) was approximately twice as high as that in 
women without MS.
Therefore, modifications in lifestyle, especially in 
terms of engagement in physical activities, can help as 
a non-drug instrument in treating risk factors for MS in 
elderly women. Despite the fact that cardiorespiratory 
aptitude is associated with all causes of mortality 
and cardiovascular diseases(5), recent studies have 
demonstrated that muscle strength and mass are 
aspects that play an important role in performing 
daily tasks, longevity, and quality of life, especially 
in elderly individuals(6,7). Also demonstrated was an 
association between muscle strength and a decrease 
in cardiovascular risk factors(8), obesity(9), high blood 
pressure(10), metabolic syndrome(11), and early death(7).
The results of the present study are in agreement with 
those presented by Tibana et al.(11), which demonstrated 
that middle-aged Brazilian women with MS showed 
less relative muscle strength when compared to women 
without MS. Similar results were presented by Miyatake 
et al.(13) after analyzing Japanese middle-aged men with 
and without MS. The study revealed that individuals 
with MS had less relative manual grip strength and lower 
limb strength when compared to the control group. 
Jurca et al.(12) and Wijndaele et al.(14) found a significant 
association between low values of muscle strength and 
the development of MS in women.
However, as far as we know, the study by Sayer et 
al.(15) was the only one developed for elderly persons 
with or without MS. Similar to the results shown in 
the present study, the elderly women with MS showed 
less relative muscle strength when compared to those 
without MS. These results increase the concern about 
elderly women with MS, since the very process of aging 
causes a significant reduction of muscle strength and 
mass, a process that compromises the performance of 
daily activities(16).
Few studies have analyzed the possible mechanisms 
associated between loss of muscle strength and mass and 
metabolic dysfunctions. It is known that skeletal muscle 
is an important determinant of the resting metabolic 
rate(22) and a target-organ for the storage of glucose(23). 
Also, Izumiya et al.(24) used genomic intervention to 
produce muscle hypertrophy in the muscle fibers of 
obese mice. The animals that had their muscle fibers 
hypertrophied by the transgenic induction of Akt1 
(mediator of muscle hypertrophy) exhibited reductions 
in body weight, in fat mass, blood glucose, insulin, 
and leptin. When there was transgenic inactivation of 
the Akt1 route, the animals lost muscle mass, which 
was associated with an increase in body fat deposition 
and circulating concentration of leptin and insulin, 
indicating a metabolic dysfunction. In this aspect, it is 
plausible to assume that the elderly women with MS 
in the present study had a lower percentage of fat-free 
mass when compared to those without MS, which may 
be associated with the metabolic dysfunctions and less 
relative muscle strength. However, this study has a cross-
sectional case-control characteristic, which impedes 
the establishment of a cause and effect relation. Thus, 
longitudinal and intervention studies are necessary in 
order to discover the possible mechanisms of muscle 
strength and mass related to MS. Other limitations of 
this study include the reduced number of participants 
and the use of medications that affect metabolism which 
are commonly used to treat MS.
Furthermore, the elderly women with MS showed 
higher concentrations of CK when compared to those 
without MS. The levels of CK were associated with 
the development of hypertension(25), and as far as 
we know, no study has analyzed the levels of CK in 
elderly women with MS. In this respect, Brewster et 
al.(26) demonstrated that in spontaneously hypertensive 
rats, the values of CK in the left ventricle and aorta 
are greater than in normotensive rats. Therefore, the 
increase in CK may be associated with vasoconstriction, 
and with increased vascular reactivity and cardiac 
contractility. However, other factors may have affected 
the circulating concentrations of CK, such as the use 
of statins to control hypercholesterolemia, since this 
medication may cause rhabdomyolysis, with acute renal 
failure and even death(27).
As per this aspect, the inclusion of the resistance 
training in elderly women seems to be clinically relevant, 
since besides increasing strength and functional 
capacity(28), it induces alterations beneficial for the 
cardiovascular and metabolic system(29) in elderly women. 
Additionally, data from this study group demonstrated 
that the resistance training does not induce a systemic 
increase in inflammatory cytokines in women with MS 
after an acute resistance exercise session(30), besides 
chronically decreasing arterial pressure and resistin 
(data not published). Nonetheless, a single resistance 
exercise session is capable of reducing arterial pressure 
during 24 hours in overweight and obese women(31). 
CONCLUSION
In conclusion, elderly women with MS demonstrated 
less relative muscle strength and greater cardiovascular 
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risk. Furthermore, elderly women with two or more risk 
factors for MS had less relative muscle strength when 
compared to those with no risk factor or with one risk 
factor for MS, which increases concern with health care. 
Additionally, the present results demonstrated that the 
elderly women with MS had a higher concentration of CK. 
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